Search by Drug Name or NDC

    NDC 51660-0058-18 Guaifenesin and Pseudoephedrine HCl 600; 60 mg/1; mg/1 Details

    Guaifenesin and Pseudoephedrine HCl 600; 60 mg/1; mg/1

    Guaifenesin and Pseudoephedrine HCl is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Ohm Laboratories, Inc.. The primary component is GUAIFENESIN; PSEUDOEPHEDRINE.

    Product Information

    NDC 51660-0058
    Product ID 51660-058_efb49ad2-ac54-4918-9c5a-7228a6dfa21c
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Guaifenesin and Pseudoephedrine HCl
    Proprietary Name Suffix n/a
    Non-Proprietary Name Guaifenesin and Pseudoephedrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 600; 60
    Active Ingredient Units mg/1; mg/1
    Substance Name GUAIFENESIN; PSEUDOEPHEDRINE
    Labeler Name Ohm Laboratories, Inc.
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA212542
    Listing Certified Through 2024-12-31

    Package

    NDC 51660-0058-18 (51660005818)

    NDC Package Code 51660-058-18
    Billing NDC 51660005818
    Package 1 BLISTER PACK in 1 CARTON (51660-058-18) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2021-04-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL efb49ad2-ac54-4918-9c5a-7228a6dfa21c Details

    Revised: 4/2021